Annie Bourdeau

2.6k total citations
30 papers, 2.1k citations indexed

About

Annie Bourdeau is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Annie Bourdeau has authored 30 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Immunology and 9 papers in Oncology. Recurrent topics in Annie Bourdeau's work include Protein Tyrosine Phosphatases (12 papers), Galectins and Cancer Biology (11 papers) and Vascular Anomalies and Treatments (8 papers). Annie Bourdeau is often cited by papers focused on Protein Tyrosine Phosphatases (12 papers), Galectins and Cancer Biology (11 papers) and Vascular Anomalies and Treatments (8 papers). Annie Bourdeau collaborates with scholars based in Canada, United States and United Kingdom. Annie Bourdeau's co-authors include Michelle Letarte, Michel L. Tremblay, Daniel Dumont, Nadia Dubé, Karen M. Doody, Krista M. Heinonen, Urszula Cymerman, Rami Sukarieh, Marilyn Carrier and Jose G. Teodoro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Annie Bourdeau

30 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annie Bourdeau Canada 21 1.3k 553 493 429 271 30 2.1k
Carmela Calés Spain 18 1.3k 1.0× 220 0.4× 251 0.5× 225 0.5× 370 1.4× 34 2.0k
Rachel A. Altura United States 25 1.3k 1.0× 270 0.5× 158 0.3× 193 0.4× 590 2.2× 48 1.9k
Mark A. Pershouse United States 15 2.4k 1.8× 289 0.5× 434 0.9× 330 0.8× 615 2.3× 33 3.1k
David R. Emlet United States 16 1.3k 1.0× 261 0.5× 157 0.3× 216 0.5× 598 2.2× 24 2.1k
Carlotta Costa United States 19 1.2k 0.9× 212 0.4× 236 0.5× 430 1.0× 669 2.5× 28 1.9k
M. S. Berger United States 19 857 0.7× 342 0.6× 198 0.4× 316 0.7× 948 3.5× 37 2.1k
Florence de Fraipont France 30 1.4k 1.1× 213 0.4× 451 0.9× 552 1.3× 637 2.4× 67 2.7k
Natasha G. Deane United States 15 1.3k 1.0× 450 0.8× 210 0.4× 273 0.6× 918 3.4× 22 2.3k
Nabendu Pore United States 17 1.4k 1.1× 244 0.4× 181 0.4× 287 0.7× 614 2.3× 26 2.3k
Suzanne Schubbert United States 12 1.7k 1.3× 540 1.0× 116 0.2× 165 0.4× 736 2.7× 22 2.3k

Countries citing papers authored by Annie Bourdeau

Since Specialization
Citations

This map shows the geographic impact of Annie Bourdeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Bourdeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Bourdeau more than expected).

Fields of papers citing papers by Annie Bourdeau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Bourdeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Bourdeau. The network helps show where Annie Bourdeau may publish in the future.

Co-authorship network of co-authors of Annie Bourdeau

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Bourdeau. A scholar is included among the top collaborators of Annie Bourdeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Bourdeau. Annie Bourdeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bourdeau, Annie, et al.. (2016). Vasculotide, an Angiopoietin-1 mimetic, ameliorates several features of experimental atopic dermatitis-like disease. BMC Research Notes. 9(1). 289–289. 7 indexed citations
2.
Cydzik, Marzena, Aws Abdul‐Wahid, Soyeon Park, et al.. (2015). Slow binding kinetics of secreted protein, acidic, rich in cysteine-VEGF interaction limit VEGF activation of VEGF receptor 2 and attenuate angiogenesis. The FASEB Journal. 29(8). 3493–3505. 15 indexed citations
3.
Kim, Harold, et al.. (2013). Cell-Cell Interactions Influence Vascular Reprogramming by Prox1 during Embryonic Development. PLoS ONE. 8(1). e52197–e52197. 16 indexed citations
4.
Cencic, Regina, Marilyn Carrier, Gabriela Galicia-Vázquez, et al.. (2009). Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol. PLoS ONE. 4(4). e5223–e5223. 241 indexed citations
5.
Doody, Karen M., Annie Bourdeau, & Michel L. Tremblay. (2009). T‐cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease. Immunological Reviews. 228(1). 325–341. 82 indexed citations
6.
Heinonen, Krista M., Annie Bourdeau, Karen M. Doody, & Michel L. Tremblay. (2009). Protein tyrosine phosphatases PTP-1B and TC-PTP play nonredundant roles in macrophage development and IFN-γ signaling. Proceedings of the National Academy of Sciences. 106(23). 9368–9372. 74 indexed citations
7.
Trop, Sébastien, Michel L. Tremblay, & Annie Bourdeau. (2008). Modulation of Bone Marrow-Derived Endothelial Progenitor Cell Activity by Protein Tyrosine Phosphatases. Trends in Cardiovascular Medicine. 18(5). 180–186. 11 indexed citations
8.
Simoncic, Paul D., Annie Bourdeau, Larry R. Rohrschneider, et al.. (2006). T-Cell Protein Tyrosine Phosphatase (Tcptp) Is a Negative Regulator of Colony-Stimulating Factor 1 Signaling and Macrophage Differentiation. Molecular and Cellular Biology. 26(11). 4149–4160. 55 indexed citations
9.
Sirois, Jacinthe, Jean‐François Côté, Alain Charest, et al.. (2006). Essential function of PTP-PEST during mouse embryonic vascularization, mesenchyme formation, neurogenesis and early liver development. Mechanisms of Development. 123(12). 869–880. 53 indexed citations
10.
Bourdeau, Annie, Nadia Dubé, & Michel L. Tremblay. (2005). Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP. Current Opinion in Cell Biology. 17(2). 203–209. 193 indexed citations
11.
Persson, C., Annie Bourdeau, Michel L. Tremblay, et al.. (2004). Site-Selective Regulation of Platelet-Derived Growth Factor β Receptor Tyrosine Phosphorylation by T-Cell Protein Tyrosine Phosphatase. Molecular and Cellular Biology. 24(5). 2190–2201. 79 indexed citations
12.
13.
Marrache, Anne Marilise, Fernand Gobeil, Sylvie G. Bernier, et al.. (2003). Platelet Activating Factor Receptors. Advances in experimental medicine and biology. 525. 161–164. 2 indexed citations
14.
Marrache, Anne Marilise, Fernand Gobeil, Sylvie G. Bernier, et al.. (2002). Proinflammatory Gene Induction by Platelet-Activating Factor Mediated Via Its Cognate Nuclear Receptor. The Journal of Immunology. 169(11). 6474–6481. 102 indexed citations
15.
Bourdeau, Annie, Marie E. Faughnan, Merry‐Lynn McDonald, et al.. (2001). Potential Role of Modifier Genes Influencing Transforming Growth Factor-β1 Levels in the Development of Vascular Defects in Endoglin Heterozygous Mice with Hereditary Hemorrhagic Telangiectasia. American Journal Of Pathology. 158(6). 2011–2020. 88 indexed citations
16.
Cho, Sarah K., Annie Bourdeau, Michelle Letarte, & Juan Carlos Zúñiga‐Pflücker. (2001). Expression and function of CD105 during the onset of hematopoiesis from Flk1+ precursors. Blood. 98(13). 3635–3642. 69 indexed citations
17.
Bourdeau, Annie, Urszula Cymerman, Marie-Ève Paquet, et al.. (2000). Endoglin Expression Is Reduced in Normal Vessels but Still Detectable in Arteriovenous Malformations of Patients with Hereditary Hemorrhagic Telangiectasia Type 1. American Journal Of Pathology. 156(3). 911–923. 104 indexed citations
18.
Bourdeau, Annie. (2000). Endoglin-deficient Mice, a Unique Model to Study Hereditary Hemorrhagic Telangiectasia. Trends in Cardiovascular Medicine. 10(7). 279–285. 96 indexed citations
19.
Bourdeau, Annie, Daniel Dumont, & Michelle Letarte. (1999). A murine model of hereditary hemorrhagic telangiectasia. Journal of Clinical Investigation. 104(10). 1343–1351. 387 indexed citations
20.
Shan, Xiaochuan, et al.. (1998). Characterization and Mapping to Human Chromosome 8q24.3 of Ly-6-Related Gene 9804 Encoding an Apparent Homologue of Mouse TSA-1. The Journal of Immunology. 160(1). 197–208. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmela Calés Breakdown of academic impact, for papers by Rachel A. Altura Breakdown of academic impact, for papers by Mark A. Pershouse Breakdown of academic impact, for papers by David R. Emlet Breakdown of academic impact, for papers by Carlotta Costa Breakdown of academic impact, for papers by M. S. Berger Breakdown of academic impact, for papers by Florence de Fraipont Breakdown of academic impact, for papers by Natasha G. Deane Breakdown of academic impact, for papers by Nabendu Pore Breakdown of academic impact, for papers by Suzanne Schubbert
Rankless by CCL
2026